| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6248600 | Transplantation Proceedings | 2014 | 5 Pages |
Abstract
Besides the difficulty in adjusting calcineurin inhibitors levels due to its interaction with antiretroviral therapy, namely with protease inhibitors, no patient had acute rejection. Furthermore, all patients presented an excellent control of viro-immunologic parameters. At the last follow-up neither cardiovascular events nor neoplastic complications were observed. Our results highlight the favorable outcome of RT in HIV-1-infected patients. The HIV-2 patient died due to severe infection, and the clinical management and potential benefit of RT in HIV-2-infected patients needs further study.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
A.T. Nunes, L. Pereira, A. Cerqueira, M. Bustorff, S. Sampaio, I. Ferreira, I. Tavares, J. Santos, M. Pestana,